Vincent Sandanayaka

1.1k total citations
31 papers, 557 citations indexed

About

Vincent Sandanayaka is a scholar working on Molecular Biology, Organic Chemistry and Cancer Research. According to data from OpenAlex, Vincent Sandanayaka has authored 31 papers receiving a total of 557 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 13 papers in Organic Chemistry and 8 papers in Cancer Research. Recurrent topics in Vincent Sandanayaka's work include Nuclear Structure and Function (8 papers), Cancer, Hypoxia, and Metabolism (6 papers) and Cyclopropane Reaction Mechanisms (6 papers). Vincent Sandanayaka is often cited by papers focused on Nuclear Structure and Function (8 papers), Cancer, Hypoxia, and Metabolism (6 papers) and Cyclopropane Reaction Mechanisms (6 papers). Vincent Sandanayaka collaborates with scholars based in United States, Canada and Italy. Vincent Sandanayaka's co-authors include Albert Padwa, Amar S. Prashad, Youjun Yang, James H. Rigby, Tarek S. Mansour, R. Thomas Williamson, Arie Zask, Sushil Rege, Jun Xu and Jeremy I. Levin and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Clinical Oncology and Blood.

In The Last Decade

Vincent Sandanayaka

31 papers receiving 518 citations

Peers

Vincent Sandanayaka
Comparison fields: 5 of 57
  • Organic Chemistry 376
  • Molecular Biology 171
  • Pharmacology 55
  • Molecular Medicine 46
  • Oncology 35
Nobuyuki Matsunaga Japan
Jason D. Brubaker United States
Rok Frlan Slovenia
Mark S. Plummer United States
Jérémie Fournier Dit Chabert France
M. Ravinder India
Stephen E. Motika United States
Lyubov G. Dezhenkova Russia
Lee D. Jennings United States
Steven J. Stanway United Kingdom
Nobuyuki Matsunaga Japan View profile →
Citations per field, relative to Vincent Sandanayaka
Vincent Sandanayaka · 1×
Citations per year, relative to Vincent Sandanayaka
Vincent Sandanayaka · 1×

Countries citing papers authored by Vincent Sandanayaka

Since Specialization
Citations

This map shows the geographic impact of Vincent Sandanayaka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vincent Sandanayaka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vincent Sandanayaka more than expected).

Fields of papers citing papers by Vincent Sandanayaka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vincent Sandanayaka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vincent Sandanayaka. The network helps show where Vincent Sandanayaka may publish in the future.

Co-authorship network of co-authors of Vincent Sandanayaka

This figure shows the co-authorship network connecting the top 25 collaborators of Vincent Sandanayaka. A scholar is included among the top collaborators of Vincent Sandanayaka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vincent Sandanayaka. Vincent Sandanayaka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Title Journal Authors Indexed citations
1 1381 Lactate modulation in cancer and immune cells is associated with antitumor efficacy of dual MCT1/MCT4 inhibitor NGY-091 Regular and Young Investigator Award Abstracts Sambad Sharma, Nelly A. Kuklin et al. 2
2 Abstract 1335: Dual MCT1/4 inhibition promotes anti-tumor immunity in triple-negative breast cancer Cancer Research Jaime A. Escobedo, Vincent Sandanayaka et al. 5
3 Abstract 1841: Selective inhibitors of nuclear export (SINE) activate multiple tumor suppressor pathways and kill prostate cancer cells across multiple genotypes in vitro and in vivo Cancer Research Giovanni Luca Gravina, Enrico Ricevuto et al. 2
4 Abstract 3775: Pharmacokinetic (PK) / pharmacodynamic (PD) and efficacy relationship of selective inhibitors of nuclear export (KPT-SINE) Cancer Research Yosef Landesman, William Senapedis et al. 1
5 CRM1/XPO1 Represents a Promising Therapeutic Target for Treatment of Chronic Lymphocytic Leukemia Blood Rosa Lapalombella, Caroline Berglund et al. 3
6 Preclinical development of small-molecule CRM1 inhibitors as novel therapy for the treatment of colorectal cancer (CRC). Journal of Clinical Oncology Sharon Shacham, Michael Kauffman et al. 2
7 Cytotoxicity of novel, small molecule, CRM1-selective inhibitors of nuclear export (SINE) in colorectal cancer (CRC) cells. Journal of Clinical Oncology Giulio Draetta, Sharon Shacham et al. 8
8 Discovery of novel leukotriene A4 hydrolase inhibitors based on piperidine and piperazine scaffolds Bioorganic & Medicinal Chemistry Letters Vincent Sandanayaka, B. Mamat et al. 6
9 Preclinical Development of Small-Molecule CRM1 Inhibitors as Novel Therapy for the Treatment of Myeloma and Other Hematological Malignancies Blood Sharon Shacham, Joel G. Turner et al. 3
10 Synthesis and activity of quinolinylmethyl P1′ α-sulfone piperidine hydroxamate inhibitors of TACE Bioorganic & Medicinal Chemistry Letters Chunchun Zhang, Frank Lovering et al. 8
11 Development of a Scalable Synthetic Process for DG-051B, A First-in-Class Inhibitior of LTA4H Organic Process Research & Development Wei Chen, Glenn L. Stahl et al. 18
12 Synthesis and SAR of diazepine and thiazepine TACE and MMP inhibitors Bioorganic & Medicinal Chemistry Letters Arie Zask, Joshua A. Kaplan et al. 23
13 Acetylenic TACE inhibitors. Part 2: SAR of six-membered cyclic sulfonamide hydroxamates Bioorganic & Medicinal Chemistry Letters Jeremy I. Levin, Leif M. Laakso et al. 45
14 Resistance to β-Lactam Antibiotics: Structure and Mechanism Based Design of β-Lactamase Inhibitors Current Medicinal Chemistry Vincent Sandanayaka, Amar S. Prashad 65
15 Allyl and propargyl substituted penam sulfones as versatile intermediates toward the syntheses of new β-lactamase inhibitors Bioorganic & Medicinal Chemistry Letters Vincent Sandanayaka, Amar S. Prashad et al. 5
16 Generation and Cycloaddition Behavior of Spirocyclic Carbonyl Ylides. Application to the Synthesis of the Pterosin Family of Sesquiterpenes The Journal of Organic Chemistry Albert Padwa, Vincent Sandanayaka et al. 45
17 ChemInform Abstract: Generation and Cycloaddition Behavior of Spirocyclic Carbonyl Ylides. Application to the Synthesis of the Pterosin Family of Sesquiterpenes. ChemInform Albert Padwa, Vincent Sandanayaka et al. 1
18 ChemInform Abstract: A New Synthetic Route to the Illudin and Pterosin Family of Sesquiterpenes ChemInform Albert Padwa, Vincent Sandanayaka et al. 1
19 Synthetic studies toward Illudins and Ptaquilosin. A highly convergent approach via the dipolar cycloaddition of carbonyl ylides Journal of the American Chemical Society Albert Padwa, Vincent Sandanayaka et al. 63
20 Intramolecular chromium(0) promoted higher-order cycloaddition reactions Tetrahedron Letters James H. Rigby, Vincent Sandanayaka 22

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026